Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00543595 | MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005) | PHASE2 | COMPLETED | 154 | — | — | Aug 1, 2004 | May 1, 2005 | May 22, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0916 | DRUG | - |
Inclusion Criteria: * Have Type 2 Diabetes * 18 to 65 years of age Exclusion Criteria: * History of Type 1 Diabetes Mellitus * Have been treated with insulin in the past 8 weeks * On a weight loss program and have ongoing weight loss * Taking weight loss medication * Have had surgery requiring ge...